Categories AlphaGraphs, Earnings, Health Care
Key highlights from Eli Lilly’s (LLY) Q1 2024 earnings results
Eli Lilly and Company (NYSE: LLY) reported first quarter 2024 earnings results today.
Worldwide revenue was $8.77 billion, up 26% from the year-ago quarter, driven by increases of 16% in volume and 10% due to higher realized prices.
Reported net income increased 67% to $2.24 billion, or $2.48 per share, compared to last year. Adjusted EPS rose 59% to $2.58.
For full-year 2024, revenue is expected to range between $42.4-43.6 billion. Reported EPS is expected to be $13.05-13.55 and adjusted EPS is estimated to be $13.50-14.00.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
After a weak first half, will NIKE (NKE) hit the recovery path this year?
After a prolonged slowdown, NIKE, Inc. (NYSE: NKE) is working on a turnaround plan to regain the brand’s strength. In recent years, the sneaker giant’s overall performance has not been
Important takeaways from Paychex’s (PAYX) Q2 2025 earnings report
Paychex Inc. (NASDAQ: PAYX), a leading provider of human resources and payroll services, reported better-than-expected revenue and profit for the second quarter of fiscal 2025, sending the stock higher soon
Lamb Weston’s (LW) challenges may not end soon, a few points to note
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) turned red in mid-day trade on Friday. The stock has dropped 19% in the past one month. The company delivered disappointing results
